US2975841048 - Common Stock
ESTRELLA IMMUNOPHARMA INC
NASDAQ:ESLA (9/6/2024, 8:10:50 PM)
1.1
+0.04 (+3.77%)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. The company is headquartered in Emeryville, California. The company went IPO on 2021-07-19. The firm is developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Its lead product candidate, EB103, utilizes Eureka's ARTEMIS technology to target CD19, a protein expressed on the surface of almost all B-cell leukemias and lymphomas. The firm is also developing EB104, which also utilizes Eureka's ARTEMIS technology to target not only CD19, but also CD22, a protein that, like CD19, is expressed on the surface of most B-cell malignancies. The firm is also collaborating with Imugene Limited and its product candidate, CF33-CD19t an oncolytic virus (CF33-CD19t), to research the use of EB103 in conjunction with CF33-CD19t to treat solid tumors.
ESTRELLA IMMUNOPHARMA INC
5858 Horton Street, Suite 370
Emeryville CALIFORNIA
P: 15103189098
Employees: 0
Website: https://www.estrellabio.com/
It's time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!
Estrella Immunopharma just reported results for the third quarter of 2024.
With our improving economy, you need to invest in these top biotech stocks that are looking to strike gold this year.
We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!
Here you can normally see the latest stock twits on ESLA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: